0.083 GBP
You can access the company’s website by clicking here.
09 Jul 2019 1 min read
Shield poised for FDA decision on Feraccru for anemia – Shield Therapeutics (STX) should hear at some point over the next two weeks whether the FDA will approve its oral iron supplement Ferracru for treatment of iron deficiency. The decision, due by 26 July, is of course important but is further complicated by a statistical issue with the […]
Invest With
Investor Type
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
You live in:
Due to data protection policies, USA residents can not access our data.
You are in:
